Lexicon Pharmaceuticals, Inc. (LXRX)
Market: NASD |
Currency: USD
Address: 2445 Technology Forest Boulevard
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain and LX2761, which is in Phase I clinical development for gastrointestinal tract. Lexicon Pharmaceuticals, Inc. has strategic collaboration and license agreements with Bristol-Myers Squibb Company and Genentech, Inc. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.
📈 Lexicon Pharmaceuticals, Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$2.93
-
Upside/Downside from Analyst Target:
292.35%
-
Broker Call:
4
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
25-50%
-
Net Income Growth Range (1Y):
0-10%
-
Revenue Growth Range (1Y):
>500%
💰 Dividend History
| Year |
Annual Yield (%) |
Total Amount |
Current Yield (%) |
Ex Date |
Pay Date |
Particulars |
| 2015 |
- |
$0.142857 |
- |
2015-05-21 |
- |
Stock split |
|
Total Amount for 2015: $0.142857 |
📅 Earnings & EPS History for Lexicon Pharmaceuticals, Inc.
| Date | Reported EPS |
|---|
| 2026-05-11 (estimated upcoming) | - |
| 2026-03-04 (estimated upcoming) | - |
| 2025-11-10 (estimated upcoming) | - |
| 2025-11-10 (estimated upcoming) | - |
| 2025-11-09 (estimated upcoming) | - |
| 2025-07-30 (estimated upcoming) | - |
| 2025-07-29 (estimated upcoming) | - |
| 2025-05-13 | - |
| 2025-04-30 | - |
| 2025-04-29 | - |
| 2025-03-09 | - |
| 2025-03-06 | -0.09 |
| 2024-11-12 | -0.18 |
| 2024-08-01 | -0.17 |
| 2024-07-31 | -0.17 |
| 2024-05-02 | -0.2 |
| 2024-05-01 | -0.2 |
| 2024-03-11 | -0.2 |
| 2024-03-10 | -0.2 |
| 2023-11-08 | -0.21 |
| 2023-11-07 | -0.21 |
| 2023-08-03 | -0.22 |
| 2023-08-02 | -0.22 |
| 2023-05-02 | -0.17 |
| 2023-05-01 | -0.17 |
| 2023-03-02 | -0.16 |
| 2023-03-01 | -0.16 |
| 2022-11-09 | -0.13 |
| 2022-11-08 | -0.13 |
| 2022-08-02 | -0.16 |
| 2022-08-01 | -0.16 |
| 2022-05-05 | -0.16 |
| 2022-05-04 | -0.16 |
| 2022-02-28 | -0.17 |
| 2022-02-27 | -0.17 |
| 2021-11-03 | -0.16 |
| 2021-11-02 | -0.16 |
| 2021-07-30 | -0.13 |
| 2021-07-29 | -0.13 |
| 2021-05-06 | -0.15 |
| 2021-05-05 | -0.15 |
| 2021-03-10 | -0.04 |
| 2021-03-09 | -0.04 |
| 2020-10-29 | 0.7 |
| 2020-10-28 | 0.7 |
| 2020-07-29 | -0.63 |
| 2020-07-28 | -0.63 |
| 2020-04-27 | -0.63 |
| 2020-04-26 | -0.63 |
| 2020-03-12 | -0.48 |
| 2020-03-11 | -0.48 |
| 2019-11-06 | 2.11 |
📰 Related News & Research
No related articles found for "lexicon pharmaceuticals".
